Innovation

Allonic: $7.2 Million Pre-Seed Funding Raised To Automate Manufacturing Of Advanced Robotic Bodies

By Amit Chowdhry ● Feb 13, 2026

Allonic, a Budapest-based robotics manufacturing startup with a joint U.S. headquarters, has raised $7.2 million in pre-seed funding to commercialize a production platform it says can dramatically simplify and scale the production of complex robotic hardware. The round was led by Visionaries Club, with backing from Day One Capital, Prototype, SDAC Ventures, and TinyVC. The company said the financing is the largest pre-seed round to date in Hungary.

Montana Capital Partners Closes $1.4 Billion OSP VI Fund After PGIM Acquisition

By Amit Chowdhry ● Feb 13, 2026

Montana Capital Partners announced it has reached a final close for MCP Opportunity Secondary Program VI, or OSP VI, a $1.4 billion private equity secondaries program focused on relative value opportunities in the mid-market. The Switzerland and U.S.-based secondaries manager said the program size matches its most recent predecessor fund and will invest across GP-led and LP-led transactions in North America and Western Europe.

Deutsche Börse To Buy General Atlantic’s Remaining ISS STOXX Stake For €1.1 Billion

By Amit Chowdhry ● Feb 13, 2026

Deutsche Börse Group has agreed to acquire the remaining 20% minority stake in ISS STOXX from General Atlantic, giving the exchange operator full ownership of the data, analytics, and index provider. The deal ends a multi-year partnership that began with Deutsche Börse Group’s 2019 acquisition of Axioma, then expanded through the 2023 combination of ISS’ stewardship and ESG solutions with the STOXX index business.

Alantra Forms €155 Million Fund To Keep Backing Health In Code

By Amit Chowdhry ● Feb 13, 2026

Alantra Private Equity has closed a €155 million healthcare continuation vehicle to increase its stake in Health in Code, positioning the Spanish clinical genomics platform for its next phase of international expansion and acquisitions. The single-asset continuation fund was significantly oversubscribed, led by Hayfin Capital Management, with additional commitments from a diversified group of institutional investors, including BNP Paribas AM and Altamar CAM.

Carlyle Acquiring Majority Stake In Nido Home Finance In $230 Million Deal

By Amit Chowdhry ● Feb 13, 2026

Edelweiss Financial Services Limited announced it will bring in The Carlyle Group as a strategic majority investor in Nido Home Finance Limited, the housing finance business that is currently a wholly owned subsidiary of Edelweiss.

Ignium Launches With $300 Million For Defense Systems

By Amit Chowdhry ● Feb 13, 2026

Albion River has launched Ignium, a purpose-built merchant provider supplying components and solutions to the U.S. and allied defense industrial base. The new platform consolidates a portfolio of established businesses that make mission-critical subsystems used across current and next-generation weapons systems, positioning Ignium as a supplier that is not dependent on the outcome of any single prime contractor or platform program.

Paragon Group Expands Business Services Provider With Parseq Acquisition

By Amit Chowdhry ● Feb 13, 2026

Paragon Group has acquired Parseq Limited, a UK-based specialist in document, finance, and payment process automation, in a deal the buyer described as a strategic investment to bolster its position in business process services. Parseq, headquartered in Hellaby, South Yorkshire, brings more than 50 years of experience providing outsourced workflow and technical solutions for highly regulated organizations with strict data and privacy requirements, including major UK banks, utilities, local authorities, and telecom operators.

Oncolytics Biotech: Interview With CEO & Director Jared Kelly About The Immunotherapy Company

By Amit Chowdhry ● Feb 13, 2026

Oncolytics Biotech is a clinical-stage biotechnology company developing pelareorep, an investigational first-in-class double-stranded RNA immunotherapeutic agent, to establish a platform immunotherapy for the treatment of gastrointestinal tumors. Pulse 2.0 interviewed Oncolytics Biotech CEO and Director Jared Kelly to learn more.

Voximplant: Interview With Founder & CEO Alexey Aylarov About The Voice AI Orchestration Platform

By Amit Chowdhry ● Feb 13, 2026

Voximplant is a Voice AI Orchestration Platform for real-time communication that enables businesses to to build and scale AI-powered communication systems without managing complex infrastructure. Pulse 2.0 interviewed Voximplant founder and CEO Alexey Aylarov to learn more.